Ten largest shareholders as of May 7, 2024
| Name | Class A-shares | Class B-shares | Share capital % | Votes % |
|---|---|---|---|---|
| ANNWALL & ROTHSCHILD INVESTMENT AB | 453,283 | 721,351 | 8.72 | 29.93 |
| SIX SIS AG W8IMY | 1,498,679 | 11.12 | 8.54 | |
| FJÄRDE AP-FONDEN | 1,344,000 | 9.98 | 7.66 | |
| NORTHERN TRUST COMPANY | 1,266,065 | 9.40 | 7.21 | |
| AMF AKTIEFOND | 601,902 | 4.47 | 3.43 | |
| UNIONEN | 532,023 | 3.95 | 3.03 | |
| TREDJE AP-FONDEN | 523,367 | 3.89 | 2.98 | |
| ÅLANDSBANKEN ABP | 409,524 | 3.04 | 2.33 | |
| DANGOOR, DAVID | 367,705 | 2.73 | 2.10 | |
| P.R BANQUE PIXTET & CIE SA | 311,169 | 2.31 | 1,77 | |
| Total 10 largest shareholders | 453,283 | 7,575,785 | 59.61 | 68.98 |
| Other Shareholder | 5,442,352 | 40.39 | 31.02 | |
| Total | 453,283 | 13,018,137 | 100 | 100 |
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 453,283 class A shares with 10 votes per share and 13,018,137 class B shares with one vote per share, in total 13,471,420 shares.